Early-onset pancreatic cancer patients benefit more from neoadjuvant chemotherapy and surgery Post author:admin Post published:August 7, 2025 Post category:uncategorized The incidence of early-onset pancreatic cancer (EOPC) is rising, yet optimal treatment strategies remain unclear. You Might Also Like Clinical Frailty Scale can quickly predict mortality in patients with heart failure October 28, 2025 The critical role of PGK1 in Parkinson’s disease August 21, 2024 Study reveals increased mental health issues among university students during COVID-19 October 30, 2024
Study reveals increased mental health issues among university students during COVID-19 October 30, 2024